What is the recommended dosage of azithromycin (macrolide antibiotic) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Azithromycin Pediatric Dosing

For most pediatric infections, administer azithromycin 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg (maximum 250 mg) once daily on days 2-5. 1, 2

Standard Dosing by Indication

Community-Acquired Pneumonia (Atypical Pathogens)

  • 10 mg/kg (max 500 mg) on day 1, then 5 mg/kg (max 250 mg) daily for days 2-5 for children ≥6 months with atypical pneumonia caused by Mycoplasma pneumoniae, Chlamydia pneumoniae, or Chlamydia trachomatis 1, 2
  • This 5-day regimen is recommended by both the American Academy of Pediatrics and the Infectious Diseases Society of America 1, 3
  • Critical caveat: Azithromycin is NOT first-line for typical bacterial pneumonia caused by S. pneumoniae or H. influenzae—amoxicillin remains the preferred agent for these pathogens 1, 2

Acute Otitis Media

  • Three FDA-approved regimens 4:
    • 30 mg/kg as a single dose (1-day regimen)
    • 10 mg/kg once daily for 3 days (3-day regimen)
    • 10 mg/kg day 1, then 5 mg/kg daily days 2-5 (5-day regimen)
  • All three regimens demonstrated equivalent efficacy to amoxicillin/clavulanic acid in clinical trials 5, 6

Acute Bacterial Sinusitis

  • 10 mg/kg once daily for 3 days for children ≥6 months 1, 4

Streptococcal Pharyngitis/Tonsillitis

  • 12 mg/kg once daily for 5 days (maximum 500 mg/day) 1
  • Important: Azithromycin is second-line therapy only—penicillin or amoxicillin remains first-line 1, 2
  • The higher dose (12 mg/kg vs. standard 10 mg/kg) is necessary because the standard regimen results in high recurrence rates 1
  • Studies show inferior bacteriologic eradication (65% vs. 82% with penicillin) despite similar clinical success rates 7

Pertussis Treatment and Prophylaxis

  • Infants <6 months: 10 mg/kg once daily for 5 days 1, 2
  • Children ≥6 months: 10 mg/kg (max 500 mg) day 1, then 5 mg/kg (max 250 mg) daily days 2-5 1
  • Azithromycin is the preferred macrolide for infants <1 month due to better safety profile compared to erythromycin 1, 3

Weight-Based Dosing Table

For children requiring weight-based dosing (when standard mg/kg calculation is impractical) 1:

  • 15-25 kg: 200 mg once daily
  • 26-35 kg: 300 mg once daily
  • 36-45 kg: 400 mg once daily
  • ≥46 kg: 500 mg once daily

Intravenous Administration

Limit IV azithromycin to days 1-2 only, then transition to oral therapy when clinically feasible 1, 2:

  • 10 mg/kg IV once daily (maximum 500 mg) on days 1 and 2 1
  • Administer at 1 mg/mL concentration over 3 hours OR 2 mg/mL concentration over 1 hour 1
  • IV azithromycin is specifically indicated for atypical pathogens requiring parenteral therapy 1

Administration Guidelines

Timing and Food

  • Azithromycin can be taken with or without food 4
  • Do NOT administer simultaneously with aluminum- or magnesium-containing antacids—separate by at least 2 hours, as antacids reduce absorption 1, 2, 3

Formulation

  • Oral suspension is the preferred formulation for children who cannot swallow tablets 1
  • Reconstitute suspension with water before administration 1

Critical Safety Considerations

Drug Interactions

  • Monitor for QT prolongation when used with other QT-prolonging medications 2, 3
  • Exercise caution with drugs metabolized by cytochrome P450 enzyme system 1

Adverse Effects

  • Common gastrointestinal effects include abdominal discomfort, diarrhea, nausea, and vomiting 1, 3
  • Azithromycin has fewer GI side effects than erythromycin 1, 2
  • Overall adverse event rate in pediatric studies: 8.7% (mostly mild-moderate severity) 6
  • Treatment discontinuation due to adverse events: only 1.3% 6

Special Populations

  • Infants <1 month: Azithromycin is safe and preferred for pertussis; not associated with infantile hypertrophic pyloric stenosis (IHPS), though monitoring is recommended 1
  • Severe renal impairment (GFR <10 mL/min): Use with caution—AUC increases 35% 4
  • Hepatic impairment: Biliary excretion is the main route of elimination; use caution 1

Common Pitfalls to Avoid

  1. Do not use azithromycin as first-line for typical bacterial pneumonia—beta-lactams remain first-line for S. pneumoniae and H. influenzae 1, 2
  2. Do not use the standard 10 mg/kg regimen for strep throat—requires 12 mg/kg daily for 5 days due to high recurrence rates 1
  3. Do not prolong IV therapy beyond 2 days when oral therapy is feasible 1, 2
  4. Do not exceed adult maximum doses regardless of weight (500 mg day 1,250 mg days 2-5) 1

Expected Clinical Response

Children on adequate azithromycin therapy should demonstrate clinical improvement within 48-72 hours 1. If the patient deteriorates or shows no improvement within this timeframe, further investigation is warranted, including assessment for complications such as parapneumonic effusion 1.

References

Guideline

Azithromycin Dosage and Administration Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Azithromycin Pediatric Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Azithromycin Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Paediatric safety of azithromycin: worldwide experience.

The Journal of antimicrobial chemotherapy, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.